Calls on regulators internationally to follow the example of the U.K. and lessen the impact of income inequality on access to better alternatives than continued smoking Philip Morris International Inc. (PMI) (NYSE: PM) announced its support of the U.K. government’s plan to simplify the pathway to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in England. The U.K. already has one of Europe’s lowest smoking rates, supported by a high rate of smokers who have switched to better alternatives. This proposal makes the U.K. the first country in the world to encourage the medical licensing of e-cigarettes via prescription as a route to further lower … Continue reading Philip Morris International Applauds U.K. Government’s Approach to Achieve its Smoke-Free Ambition

Interview with Zyon Ayni, Founder and CEO of Code Pharma As researchers, scientists and antivirus specialists work around the clock to identify ways to help protect individuals and communities across the globe against the pandemic, Netherlands based Code Pharma, led by Zyon Ayni, is one step ahead of the game with Codivir, a potential game changer medication that gets COVID-19 affected patients up and about within 48 hours with no side effects. Code Pharma is now initiating a phase 2 controlled study to be conducted in several countries with a larger cohort and has already submitted emergency approval requests to … Continue reading Healing Hands: CODIVIR – The COVID-19 Cure Is In Sight